CAGRILINTIDE 10mg

$48.00

Cagrilintide is a synthetic, long-acting amylin receptor agonist engineered to provide sustained biological activity through strategic amino acid modifications and fatty acid acylation technology. Developed as an advanced analog of the naturally occurring hormone amylin, Cagrilintide has emerged as a significant research compound in studies focused on metabolic regulation, energy balance, appetite signaling, and body composition.

Amylin is a peptide hormone co-secreted with insulin by pancreatic beta cells and plays an important role in regulating nutrient intake, gastric motility, satiety signaling, and postprandial metabolic responses. Cagrilintide was specifically designed to enhance the stability and duration of amylin receptor activation, providing researchers with a powerful tool for investigating the physiological mechanisms that govern hunger, energy expenditure, and metabolic homeostasis.

Through its prolonged receptor engagement, Cagrilintide has been studied for its effects on appetite regulation, caloric intake, gastric emptying, and overall energy balance. These characteristics have generated considerable interest in obesity research, weight management models, and investigations examining the neuroendocrine pathways involved in metabolic control.

Beyond its role in appetite signaling, researchers have explored the broader implications of amylin receptor activation on glucose metabolism, insulin sensitivity, adipose tissue biology, and long-term metabolic adaptation. Its unique pharmacological profile offers valuable insights into the complex communication networks that connect the gastrointestinal system, pancreas, and central nervous system in the regulation of energy homeostasis.

As scientific understanding of metabolic peptides continues to evolve, Cagrilintide remains an important research tool for exploring the intersection of appetite control, body weight regulation, glucose homeostasis, and metabolic health. Its extended duration of action and targeted receptor activity have established it as a leading compound in next-generation metabolic and obesity research.

CAS NO: 1415456-99-3
Molecular Formula: C194H312N54O59S2
Molecular Weight: 4,409 g/mol
Appearance: White Powder

Research Use Only
This product is intended solely for in vitro laboratory research purposes. It is not approved for human or animal use and must not be used in food, dietary supplements, pharmaceuticals, or cosmetic applications. All products arrive in lyophilized (freeze-dried) powder form.

Legal Disclaimer
This product and any associated information have not been evaluated by the U.S. Food and Drug Administration (FDA). No representations or warranties are made regarding its use for the diagnosis, treatment, cure, or prevention of any disease. Use is strictly limited to qualified professionals operating in properly equipped and certified laboratory environments.

Terms of Sale
By purchasing from Cutting Edge Compounds, the buyer certifies that they are a qualified researcher or represent a licensed institution. The buyer assumes full responsibility for ensuring compliance with all applicable laws and regulations governing the purchase, handling, storage, and use of this product. All sales are final.

STRENGHT

BATCH/LOT

RECEIVED

PURITY

COA

10mg

CEC-CAG-10-01

July 2026

99.4%

DOWNLOAD